Table 1.

Four digital health segments used to evaluate biopharmaceutical company maturity.

Digital health segments	Definition
Clinical research and drug discovery	Process improvements in clinical research and drug development enabled by digital health to realize clinical benefits.
Lifecycle management	Continuous monitoring and improvement of the product or service through real-world evidence generation to meet the needs of the end user until product end of life.
Product commercialization	Digital health extensions of the molecule’s capabilities outside of pure pharmacokinetic or pharmacodynamic impacts that increase the value of the molecule.
Beyond the molecule	Hardware or software solutions that provide therapeutic benefits independent of the molecule.